Delayed
Hong Kong S.E.
23:30:50 2024-05-02 EDT
|
5-day change
|
1st Jan Change
|
3.43
HKD
|
+0.88%
|
|
+9.24%
|
-31.40%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
---|
Capitalization
1 |
4,833
|
7,061
|
2,104
|
Enterprise Value (EV)
1 |
4,039
|
6,819
|
2,175
|
P/E ratio
|
-9.49
x
|
-19.9
x
|
-6.6
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
EV / EBITDA
|
-12.1
x
|
-21
x
|
-9.41
x
|
EV / FCF
|
-41,571,620
x
|
-33,848,331
x
|
-14,859,534
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
Price to Book
|
4.29
x
|
8.59
x
|
4.14
x
|
Nbr of stocks (in thousands)
|
514,584
|
514,584
|
514,584
|
Reference price
2 |
9.393
|
13.72
|
4.089
|
Announcement Date
|
21-04-20
|
23-04-25
|
23-04-25
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-42.32
|
-92.1
|
-334
|
-324.3
|
-231.1
|
EBIT
1 |
-44.3
|
-97.73
|
-347.7
|
-345.2
|
-274.2
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-34.89
|
-109.1
|
-439.1
|
-354.6
|
-321.1
|
Net income
1 |
-34.77
|
-108.8
|
-439
|
-354.2
|
-318.1
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.1061
|
-0.2900
|
-0.9900
|
-0.6900
|
-0.6200
|
Free Cash Flow
|
-
|
-65.45
|
-97.16
|
-201.4
|
-146.3
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-06-29
|
20-06-29
|
21-04-20
|
23-04-25
|
23-04-25
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
70.3
|
Net Cash position
1 |
140
|
243
|
794
|
242
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.3044
x
|
Free Cash Flow
|
-
|
-65.5
|
-97.2
|
-201
|
-146
|
ROE (net income / shareholders' equity)
|
-
|
-39%
|
-59.7%
|
-36.3%
|
-48.3%
|
ROA (Net income/ Total Assets)
|
-
|
-17.5%
|
-26.7%
|
-18.7%
|
-17.3%
|
Assets
1 |
-
|
620
|
1,644
|
1,895
|
1,835
|
Book Value Per Share
2 |
0.6600
|
0.4400
|
2.190
|
1.600
|
0.9900
|
Cash Flow per Share
2 |
0.3900
|
0.7400
|
1.640
|
0.6900
|
0.1100
|
Capex
1 |
35.1
|
13.8
|
25
|
146
|
68.2
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-06-29
|
20-06-29
|
21-04-20
|
23-04-25
|
23-04-25
|
|
1st Jan change
|
Capi.
|
---|
| -31.40% | 216M | | -1.65% | 104B | | +6.75% | 97.47B | | +5.71% | 22.25B | | -12.60% | 21.68B | | -9.70% | 18.2B | | -39.98% | 17.02B | | -10.17% | 16.36B | | +6.12% | 14.39B | | +35.47% | 12.37B |
Bio Therapeutic Drugs
|